However, BNP may not increase proportionally in heart failure patients, and NT-pro-BNP is primarily excreted by the kidney, so plasma concentrations of this latter biomarker may be intrinsically higher in patients with CKD [61, 62]. This evidence concerns the gene NPPB and chronic kidney disease.